Shiyovich Arthur, Shlomo Nir, Cohen Tal, Iakobishvili Zaza, Kornowski Ran, Eisen Alon
Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Israeli Center of Cardiovascular Research, Tel Hashomer, Israel.
Int J Cardiol. 2020 Apr 1;304:8-13. doi: 10.1016/j.ijcard.2020.01.040. Epub 2020 Jan 21.
Multi-vessel coronary artery disease (MV-CAD) is common among patients with acute coronary syndrome (ACS) and is associated with worse outcomes.
To examine temporal trends of patients presenting with ACS and MV-CAD.
Time-dependent analysis of patients enrolled in the ACS Israeli Surveys (ACSIS) between 2004-2016 by 3 time periods: early (2004-2006; n = 2111), mid (2008-2010; n = 2049), and late (2013-2016; n = 2010). MV-CAD was defined as >50% stenosis in ≥2 separate coronary territories at the index coronary catheterization. Outcomes were 30-day MACE and 1-year all-cause mortality.
Overall 6170/9321 patients (66%) had MV-CAD (age 64.5 ± 12.1, males 80%). Patients from later periods were older with a higher prevalence of cardiovascular risk-factors and comorbidity. Among patients with MV-CAD, STEMI decreased significantly (early-46% vs. late-37%, p < 0.001). The rates of PCI were similar, however rates of MV-PCI have increased (early-16.8% vs. late -37.1%, p < 0.001) while the rates of CABG decreased over-time (early-12.7% vs. late -9.2%, p < 0.001). Thirty-day outcomes improved significantly; MACE (early-18.2%, mid-12.6%, late-11.2%, p < 0.001), mortality (early-4.7%, mid-4.2%, late-3.1%, p = 0.03) and re-infarction (early = 3.0%, mid = 2.4% and late 1.1%, p < 0.001). No significant change in 1-year mortality was observed (early = 9.3%, mid = 7.8%, late = 7.7%, p = 0.13). A multivariate adjusted analysis demonstrated that the mid and late periods (vs. the early period) were associated with significantly reduced risk for 30-day MACE (OR = 0.65 [0.54-0.77] and 0.54 [0.45-0.65], respectively).
During the last decade, the burden of cardiovascular risk factors among ACS patients with MV- CAD has increased, more invasive treatment was provided and a significant improvement in 30-day outcomes was observed.
多支冠状动脉疾病(MV-CAD)在急性冠状动脉综合征(ACS)患者中很常见,且与更差的预后相关。
研究出现ACS和MV-CAD的患者的时间趋势。
对2004年至2016年参加以色列ACS调查(ACSIS)的患者进行时间依赖性分析,分为3个时间段:早期(2004-2006年;n = 2111)、中期(2008-2010年;n = 2049)和晚期(2013-2016年;n = 2010)。MV-CAD定义为在首次冠状动脉导管插入术中,≥2个独立冠状动脉区域出现>50%的狭窄。观察的结局指标为30天主要不良心血管事件(MACE)和1年全因死亡率。
总体上,6170/9321例患者(66%)患有MV-CAD(年龄64.5±12.1岁,男性占80%)。后期的患者年龄更大,心血管危险因素和合并症的患病率更高。在患有MV-CAD的患者中,ST段抬高型心肌梗死(STEMI)显著减少(早期为46%,晚期为37%,p<0.001)。经皮冠状动脉介入治疗(PCI)的比例相似,但多支血管PCI的比例有所增加(早期为16.8%,晚期为37.1%,p<0.001),而冠状动脉旁路移植术(CABG)的比例随时间下降(早期为12.7%,晚期为9.2%,p<0.001)。30天结局有显著改善;MACE(早期为18.2%,中期为12.6%,晚期为11.2%,p<0.001)、死亡率(早期为4.7%,中期为4.2%,晚期为3.1%,p = 0.03)和再梗死率(早期为3.0%,中期为2.4%,晚期为1.1%,p<0.001)。1年死亡率无显著变化(早期为9.3%,中期为7.8%,晚期为7.7%,p = 0.13)。多变量调整分析表明,中期和晚期(与早期相比)与30天MACE风险显著降低相关(OR分别为0.65[0.54-0.77]和0.54[0.45-0.65])。
在过去十年中,患有MV-CAD的ACS患者的心血管危险因素负担增加,接受了更多的侵入性治疗,并且30天结局有显著改善。